Augmentation procedure failure · Patients with missing teeth and an atrophic posterior maxilla, with residual bone height between 4 and 9 mm below the maxillary sinus
1 finding from 1 review
Implant failure · Patients with missing teeth and an atrophic posterior maxilla, with residual bone height between 4 and 9 mm below the maxillary sinus
Maxillary sinus lift (augmentation) with long implants showed no clear difference in implant failure compared with short implants (5 to 8.5 mm) without sinus augmentation (moderate certainty).
1 finding from 1 review
Partial graft loss · Patients with 3 to 6 mm of residual bone height at the sinus floor
One-stage crestal-approach sinus lift with autogenous bone and 8 mm… showed no clear difference in partial graft loss compared with lateral-window sinus lift with 50% autogenous bone/50% Bio-Oss and…; GRADE not reported.
1 finding from 1 review
Implant failure · Patients with 2 to 7 mm of residual alveolar bone height in the edentulous maxillary sinus floor
One-stage lateral sinus lift with monocortical autogenous bone… showed no clear difference in implant failure compared with two-stage lateral sinus lift with autogenous particulate bone (iliac…; GRADE not reported.
1 finding from 1 review
Plaque · Individuals of any age with no reported disability that might affect toothbrushing (including people wearing orthodontic appliances)
Powered toothbrush, circular action showed no clear difference in plaque score (1 to 3 months) compared with manual toothbrush; GRADE not reported.
1 finding from 1 review
Staining · Individuals of any age with no reported disability that might affect toothbrushing (including people wearing orthodontic appliances)
1 finding from 1 review
Gingivitis · Individuals of any age with no reported disability that might affect toothbrushing (including people wearing orthodontic appliances)
Powered toothbrush, side-to-side action showed no clear difference in gingivitis score (>3 months) compared with manual toothbrush; GRADE not reported.
2 findings from 1 review
Gingivitis · Individuals of any age with no reported disability that might affect toothbrushing (including people wearing orthodontic appliances)
Powered toothbrush, ultrasonic action led to lower gingivitis score (1 to 3 months) compared with manual toothbrush; GRADE not reported.
2 findings from 1 review
Powered versus manual toothbrushing for oral health 2014 · Cochrane All outcomesShort term (1 to 3 months)
SMD -0.99 [-1.21, -0.76]
5 studies · 354 participants
GRADE not reported
Ultrasonic vs manual, gingivitis at >3 months: one trial (Terezhalmy 1995a); no statistically significant difference; totals not selected (no pooled estimate presented in this version).
1 study · 46 participants
GRADE not reported
Gingivitis · Individuals of any age with no reported disability that might affect toothbrushing (including people wearing orthodontic appliances)
2 findings from 1 review
Unknown/other action vs manual, gingivitis at >3 months: 1 trial; totals not selected.
1 study
GRADE not reported
Powered versus manual toothbrushing for oral health 2014 · Cochrane All outcomesShort term (1 to 3 months)
Unknown/other action vs manual, gingivitis at 1 to 3 months: 3 trials; totals not selected (data presented in forest plots but not pooled).
3 studies
GRADE not reported
Gingivitis · Individuals of any age with no reported disability that might affect toothbrushing (including people wearing orthodontic appliances)
Powered toothbrush, counter oscillation action showed no clear difference in gingivitis score (1 to 3 months) compared with manual toothbrush; GRADE not reported.
2 findings from 1 review
Gingivitis · Individuals of any age with no reported disability that might affect toothbrushing (including people wearing orthodontic appliances)
Powered toothbrush (any mode of action) probably leads to lower gingivitis score (1 to 3 months) compared with manual toothbrush (moderate certainty).
2 findings from 1 review
Implant failure · Patients undergoing one-stage crestal maxillary sinus lift without bone grafts (baseline residual bone height about 6.5 mm)
Hand mallet (osteotomes) showed no clear difference in implant failure compared with electric mallet; GRADE not reported.
1 finding from 1 review
Prosthesis failure · Patients with 3 to 6 mm of residual bone height at the sinus floor
One-stage crestal-approach sinus lift with autogenous bone and 8 mm… showed no clear difference in prosthesis failure compared with lateral-window sinus lift with 50% autogenous bone/50% Bio-Oss and…; GRADE not reported.
1 finding from 1 review
Prosthesis failure · Patients with an atrophic maxillary sinus requiring augmentation (1 to 5 mm residual bone height)
Sinus lift with bone graft (granular Bio-Oss) showed no clear difference in prosthesis failure compared with sinus lift without bone graft (Inion resorbable rigid barrier…; GRADE not reported.
1 finding from 1 review
Adverse events (soft tissue trauma) · Individuals of any age with no reported disability that might affect toothbrushing (including people wearing orthodontic appliances)
1 finding from 1 review
Augmentation procedure failure · Patients undergoing one-stage crestal maxillary sinus lift without bone grafts (baseline residual bone height about 6.5 mm)
1 finding from 1 review
Cancer occurrence · healthy participants or recruited among the general population; individuals diagnosed with a specific disease in a stable phase or with…
Vitamin D showed no clear difference in cancer occurrence compared with placebo or no intervention (moderate certainty).
1 finding from 1 review
Cancer occurrence in trials using vitamin D₃ (cholecalciferol) · healthy participants or recruited among the general population; individuals diagnosed with a specific disease in a stable phase or with…
Vitamin D showed no clear difference in cancer occurrence in trials using vitamin D₃ (cholecalciferol) compared with placebo or no intervention (moderate certainty).
1 finding from 1 review
All‐cause mortality · healthy participants or recruited among the general population; individuals diagnosed with a specific disease in a stable phase or with…
Vitamin D may leads to lower all‐cause mortality compared with placebo or no intervention (low certainty).
1 finding from 1 review
Cancer mortality in trials using vitamin D3 (cholecalciferol) ( · healthy participants or recruited among the general population; individuals diagnosed with a specific disease in a stable phase or with…
Vitamin D may leads to lower cancer mortality in trials using vitamin D₃(cholecalciferol) compared with placebo or no intervention (low certainty).
1 finding from 1 review